Andrea Kranzer
CEO @ Balloonas
Mannheim, Germany
Andrea Kranzer is an angel investor based in Mannheim, Germany. She invests in IT and healthcare Startups mainly in the seed and early-stage phase. Her special areas of expertise are strategy development, business modelling and marketing. She is a respected speaker and mentor in the German Startup Scene. Besides that, she is founder and CEO of„balloonas“, an internet plattform for kids-birthday-parties, which provides cool ideas and planning tools for parents who are organizing a kids birthday party. She holds a PhD degree in healthcare economics and worked for Roche Diagnostics and Bertelsmann.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Andrea Kranzer invests in
Stages Andrea Kranzer invests in
Countries Andrea Kranzer invests in
Investment Focus
Industry
- Software 2 (67%)
- B2B 1 (33%)
- Music 1 (33%)
- Medical 1 (33%)
- Big Data 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
aiomics
|
Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers. | $2.3M / Pre-Seed / Aug 18, 2025 | |
|
aiomics
|
Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers. | Pre-Seed / Apr 19, 2025 | |
Cyanite
|
As one of Europe's leading and independent innovators in music AI, Cyanite's clients consist of a variety of high-profile and forward-thinking companies in the fields of music and audio.The mission of Cyanite is to support music companies in making the shift on their way to the age of AI without spending years and expensive resources oninnovation. Cyanite enables them to revolutionize their music databases with modern algorithms, optimize their workflows, and generate more revenues by bringing their long-tail strategies to life.The diverse team of engineers, data scientists, and music industry professionals come from backgrounds in music, either as musicians or passionate fans. With more than 20 years of combined experience in deep learning and music information retrieval, it’s their deepest motivation to help building and sustaining a diverse, culturally rich, and human-centered music industry. | $818.1K / Seed / Jul 29, 2022 |
Co-Investors
Calm/Storm VC
1 deal together
LionCorn Capital
1 deal together
Norrsken Evolve
1 deal together
rule30
1 deal together
About Balloonas
Balloonas Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrea Kranzer
CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Andrea Kranzer invest in?
Andrea Kranzer invests primarily in Software, B2B and Music startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrea Kranzer last invest?
The most recent investment recorded for Andrea Kranzer closed in Aug 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
